1.
|
27 p, 1.5 MB |
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease : A prospective multicohort study of the ABIRISK consortium
/
Hässler, Signe (Hôpital Pitié-Salpêtrière) ;
Bachelet, Delphine (Hôpital Bichat) ;
Duhaze, Julianne (CHU Ste-Justine Research Center) ;
Szely, Natacha (Paris-Sud University) ;
Gleizes, Aude (Le Kremlin-Bicêtre Hospital) ;
Hacein-Bey Abina, Salima (Paris-Descartes-Sorbonne-Cite University) ;
Aktas, Orhan (University of Düsseldorf) ;
Auer, Michael (Innsbruck Medical University) ;
Avouac, Jerôme (Cochin Hospital) ;
Birchler, Mary (GlaxoSmithKline (Estats Units d'Amèrica)) ;
Bouhnik, Yoram (GETAID (França)) ;
Brocq, Olivier (Princess Grace Hospital) ;
Buck-Martin, Dorothea (Technische Universität München) ;
Cadiot, Guillaume (University Hospital of Reims) ;
Carbonnel, Franck (Hôpital Kremlin-Bicêtre) ;
Chowers, Yehuda (Rambam Health Care Campus) ;
Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Derfuss, Tobias (University Hospital Basel (Basilea, Suïssa)) ;
Sikkema, Dan (University of Amsterdam) ;
Donnellan, Naoimh (Ipsen Biopharm (Regne Unit)) ;
Doukani, Abiba (Sorbonne Université) ;
Guger, Michael (Kepler University Hospital) ;
Hartung, Hans-Peter (University of Düsseldorf) ;
Kubala Havrdova, Eva (Charles University and General University Hospital, Prague, Czech Republic) ;
Hemmer, Bernhard (Munich Cluster for Systems Neurology) ;
Huizinga, Tom (Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands) ;
Ingenhoven, Kathleen (University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany) ;
Hyldgaard-Jensen, Poul Erik (Copenhagen University Hospital Rigshospitalet) ;
Jury, Elizabeth C. (University College London) ;
Khalil, Michael (Medical University of Graz) ;
Kieseier, Bernd (University of Düsseldorf) ;
Lindberg, Raija (University Hospital Basel (Basilea, Suïssa)) ;
Loercher, Amy (GlaxoSmithKline (Estats Units d'Amèrica)) ;
Maggi, Enrico (Bambino Gesù Children's Hospital) ;
Manson, Jessica (University College London Hospital) ;
Mauri, Claudia (University College London) ;
Mohand Oumoussa, Badreddine (Sorbonne Université) ;
Montalban, Xavier (St. Michael's Hospital) ;
Nachury, Maria (University Hospital of Lille (França)) ;
Nytrova, Petra (Charles University. Faculty of Medicine in Hradec Králové) ;
Richez, Christophe (Bordeaux University) ;
Ryner, Malin (Karolinska Institutet (Estocolm, Suècia)) ;
Sellebjerg, Finn (Copenhagen University Hospital Rigshospitalet) ;
Sievers, Claudia (University Hospital Basel (Basilea, Suïssa)) ;
Sikkema, Dan (Quanterix Corporation (Estats Units d'Amèrica)) ;
Soubrier, Martin (University Hospital of Clermont Ferrand) ;
Tourdot, Sophie (Paris-Sud University) ;
Trang, Caroline (CHU de Nantes) ;
Vultaggio, Alessandra (Università di Firenze) ;
Warnke, Clemens (University Hospital Köln) ;
Spindeldreher, Sebastian (Integrated Biologix GmbH (Suïssa)) ;
Dönnes, Pierre (SciCross AB (Suècia)) ;
Hickling, Timothy P. (Pfizer (Estats Units d'Amèrica)) ;
Hincelin Mery, Agnès (Sanofi, Chilly-Mazarin, France) ;
Allez, Matthieu (Hôpital Saint-Louis, AP-HP) ;
Deisenhammer, Florian (Innsbruck Medical University) ;
Fogdell-Hahn, Anna (Karolinska Institutet (Estocolm, Suècia)) ;
Mariette, Xavier (Université Paris-Saclay) ;
Pallardy, Marc (Paris-Sud University) ;
Broët, Philippe (Paris-Sud University Hospitals) ;
Universitat Autònoma de Barcelona
Biopharmaceutical products (BPs) are widely used to treat autoimmune diseases, but immunogenicity limits their efficacy for an important proportion of patients. Our knowledge of patient-related factors influencing the occurrence of antidrug antibodies (ADAs) is still limited. [...]
2020 - 10.1371/journal.pmed.1003348
PLoS Medicine, Vol. 17 (october 2020)
|
|
2.
|
8 p, 676.9 KB |
Off-label use of rituximab for systemic lupus erythematosus in Europe
/
Rydén-Aulin, Monica (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Boumpas, Dimitrios (Kapodestrian University of Athens) ;
Bultink, Irene (Amsterdam Rheumatology and Immunology Center) ;
Callejas Rubio, Jose Luis (Hospital Universitario San Cecilio (Granada)) ;
Caminal-Montero, Luis (Hospital Universitario Central de Asturias) ;
Castro, Antoni (Hospital Universitari Sant Joan de Reus (Tarragona)) ;
Colodro Ruiz, Agustín ;
Doria, Andrea (University of Padova) ;
Dörner, Thomas (Charite Universitaetsmedizin Berlin) ;
González-Echávarri, Cristina (Instituto de Investigación Sanitaria Biocruces Bizkaia) ;
Gremese, Elisa (Institute of Rheumatology and Affine Sciences (IRSA), Catholic University of the Sacred Heart) ;
Houssiau, Frederic A. (Université Catholique de Louvain) ;
Huizinga, Tom ;
Inanç, Murat (Istanbul University) ;
Isenberg, David (University College London) ;
Iuliano, Annamaria (San Camillo Forlanini Hospital) ;
Jacobsen, Søren (University of Copenhagen) ;
Jimenéz-Alonso, Juan (Hospital Universitario Virgen de las Nieves (Granada)) ;
Kovács, Lászlo (University of Szeged. Albert Szent-Györgyi Health Centre) ;
Mariette, Xavier (Université Paris-Sud) ;
Mosca, Marta (Rheumatology Unit, Pisa) ;
Nived, Ola (Skåne University Hospital (Suècia)) ;
Oristrell, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Ramos-Casals, Manuel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Rascón, Javier ;
Ruiz-Irastorza, Guillermo (Instituto de Investigación Sanitaria Biocruces Bizkaia) ;
Sáez-Comet, Luis (Hospital Universitario Miguel Servet (Saragossa)) ;
Salvador Cervelló, Gonzalo (Hospital Universitari i Politècnic La Fe (València)) ;
Sebastiani, Gian Domenico (Ospedale San Camillo) ;
Squatrito, Danilo (University of Florence) ;
Szücs, Gabriella (Institute of Medicine, University of Debrecen) ;
Voskuyl, Alexandre (Amsterdam Rheumatology and Immunology Center (ARC)) ;
van Vollenhoven, Ronald (Amsterdam Rheumatology and Immunology Center ARC)
Rituximab (RTX) is a biological treatment used off-label in patients with systemic lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in Europe and compare the characteristics of patients receiving RTX with those receiving conventional therapy. [...]
2016 - 10.1136/lupus-2016-000163
Lupus Science & Medicine, Vol. 3 (september 2016)
|
|